Abstract

The patent application protects nontoxic small molecules (glycomimetics), easily obtained from natural compounds (carbohydrates), which can be used for personalized treatment of glycan-related diseases

Research Institution

Università degli Studi di Firenze

Numero di pubblicazione

WO2022146978A1

TRL

4

Technologies, Systems, Applications

Biotechnologies, New drugs development